A citation-based method for searching scientific literature

L Balducci, D Goetz-Parten, M A Steinman. Ann Oncol 2013
Times Cited: 60







List of co-cited articles
282 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Patient Characteristics Associated with Polypharmacy and Inappropriate Prescribing of Medications among Older Adults with Cancer.
Gopi K Prithviraj, Siran Koroukian, Seunghee Margevicius, Nathan A Berger, Rakesh Bagai, Cynthia Owusu. J Geriatr Oncol 2012
92
28

Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study.
Arti Hurria, Kayo Togawa, Supriya G Mohile, Cynthia Owusu, Heidi D Klepin, Cary P Gross, Stuart M Lichtman, Ajeet Gajra, Smita Bhatia, Vani Katheria,[...]. J Clin Oncol 2011
28

Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score.
Martine Extermann, Ivette Boler, Richard R Reich, Gary H Lyman, Richard H Brown, Joseph DeFelice, Richard M Levine, Eric T Lubiner, Pablo Reyes, Frederic J Schreiber,[...]. Cancer 2012
637
28


Prevalence and factors associated with polypharmacy in older people with cancer.
Justin P Turner, Sepehr Shakib, Nimit Singhal, Jonathon Hogan-Doran, Robert Prowse, Sally Johns, J Simon Bell. Support Care Cancer 2014
80
25

Polypharmacy in older adults with cancer.
Ronald J Maggiore, Cary P Gross, Arti Hurria. Oncologist 2010
116
25


Medication problems in older, newly diagnosed cancer patients in Canada: How common are they? A prospective pilot study.
Martine T E Puts, Beatriz Costa-Lima, Johanne Monette, Veronique Girre, Christina Wolfson, Gerald Batist, Howard Bergman. Drugs Aging 2009
52
23


The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML).
Kathleen Elliot, Janet A Tooze, Rachel Geller, Bayard L Powell, Timothy S Pardee, Ellen Ritchie, LeAnne Kennedy, Kathryn E Callahan, Heidi D Klepin. Leuk Res 2014
47
21

Polypharmacy in patients with advanced cancer and the role of medication discontinuation.
Thomas W LeBlanc, Michael J McNeil, Arif H Kamal, David C Currow, Amy P Abernethy. Lancet Oncol 2015
85
16


Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy.
Mihaela A Popa, Kristie J Wallace, Antonella Brunello, Martine Extermann, Lodovico Balducci. J Geriatr Oncol 2014
62
15

Polypharmacy and potentially inappropriate medication use in geriatric oncology.
Manvi Sharma, Kah Poh Loh, Ginah Nightingale, Supriya G Mohile, Holly M Holmes. J Geriatr Oncol 2016
89
15

Potential drug interactions and duplicate prescriptions among cancer patients.
Rachel P Riechelmann, Ian F Tannock, Lisa Wang, Everardo D Saad, Nathan A Taback, Monika K Krzyzanowska. J Natl Cancer Inst 2007
195
13

STOPP/START criteria for potentially inappropriate prescribing in older people: version 2.
Denis O'Mahony, David O'Sullivan, Stephen Byrne, Marie Noelle O'Connor, Cristin Ryan, Paul Gallagher. Age Ageing 2015
13

Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatment.
Ronald J Maggiore, William Dale, Cary P Gross, Tao Feng, William P Tew, Supriya G Mohile, Cynthia Owusu, Heidi D Klepin, Stuart M Lichtman, Ajeet Gajra,[...]. J Am Geriatr Soc 2014
86
13


Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients.
Ali Alkan, Arzu Yaşar, Ebru Karcı, Elif Berna Köksoy, Muslih Ürün, Filiz Çay Şenler, Yüksel Ürün, Gülseren Tuncay, Hakan Ergün, Hakan Akbulut. Support Care Cancer 2017
34
20

Potentially inappropriate medication use in older people with cancer: prevalence and correlates.
Laura K Saarelainen, Justin P Turner, Sepehr Shakib, Nimit Singhal, Jonathon Hogan-Doran, Robert Prowse, Sally Johns, Judith Lees, J Simon Bell. J Geriatr Oncol 2014
31
19

The treatment of co-morbidities in older patients with metastatic cancer.
Josephine Cashman, Juliet Wright, Alistair Ring. Support Care Cancer 2010
30
20

International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer.
Hans Wildiers, Pieter Heeren, Martine Puts, Eva Topinkova, Maryska L G Janssen-Heijnen, Martine Extermann, Claire Falandry, Andrew Artz, Etienne Brain, Giuseppe Colloca,[...]. J Clin Oncol 2014
878
10

Reply to M.-E. Rougé Bugat et al.
Ginah Nightingale, Kristine Swartz, Andrew E Chapman. J Clin Oncol 2015
35
17

Polypharmacy cut-points in older people with cancer: how many medications are too many?
Justin P Turner, Kris M Jamsen, Sepehr Shakib, Nimit Singhal, Robert Prowse, J Simon Bell. Support Care Cancer 2016
77
10

What is polypharmacy? A systematic review of definitions.
Nashwa Masnoon, Sepehr Shakib, Lisa Kalisch-Ellett, Gillian E Caughey. BMC Geriatr 2017
789
10

Potential for drug interactions in hospitalized cancer patients.
Rachel Pimenta Riechelmann, Frederico Moreira, Oren Smaletz, Everardo D Saad. Cancer Chemother Pharmacol 2005
92
8

Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.
Danijela Gnjidic, Sarah N Hilmer, Fiona M Blyth, Vasi Naganathan, Louise Waite, Markus J Seibel, Andrew J McLachlan, Robert G Cumming, David J Handelsman, David G Le Couteur. J Clin Epidemiol 2012
627
8

Prognostic indices for older adults: a systematic review.
Lindsey C Yourman, Sei J Lee, Mara A Schonberg, Eric W Widera, Alexander K Smith. JAMA 2012
478
8

Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study.
Philippe Caillet, Florence Canoui-Poitrine, Johanna Vouriot, Muriel Berle, Nicoleta Reinald, Sebastien Krypciak, Sylvie Bastuji-Garin, Stephane Culine, Elena Paillaud. J Clin Oncol 2011
276
8

Concomitant polypharmacy is associated with irinotecan-related adverse drug reactions in patients with cancer.
Tetsuya Sasaki, Ken-Ichi Fujita, Yu Sunakawa, Hiroo Ishida, Keishi Yamashita, Keisuke Miwa, Shigehira Saji, Yasuhisa Kato, Yasutsuna Sasaki. Int J Clin Oncol 2013
24
20

Comprehensive geriatric assessment of risk factors associated with adverse outcomes and resource utilization in cancer patients undergoing abdominal surgery.
Brian Badgwell, Jordan Stanley, George J Chang, Matthew H G Katz, Heather Y Lin, Jing Ning, Suzanne V Klimberg, Janice N Cormier. J Surg Oncol 2013
78
8

Underrepresentation of patients 65 years of age or older in cancer-treatment trials.
L F Hutchins, J M Unger, J J Crowley, C A Coltman, K S Albain. N Engl J Med 1999
8



Unnecessary drug use in frail older people at hospital discharge.
Emily R Hajjar, Joseph T Hanlon, Richard J Sloane, Catherine I Lindblad, Carl F Pieper, Christine M Ruby, Laurence C Branch, Kenneth E Schmader. J Am Geriatr Soc 2005
126
8

Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study.
Lazzaro Repetto, Lucia Fratino, Riccardo A Audisio, Antonella Venturino, Walter Gianni, Marina Vercelli, Stefano Parodi, Denise Dal Lago, Flora Gioia, Silvio Monfardini,[...]. J Clin Oncol 2002
591
8

The influence of polypharmacy on grade III/IV toxicity, prior discontinuation of chemotherapy and overall survival in ovarian cancer.
H Woopen, R Richter, F Ismaeel, R Chekerov, I Roots, T Siepmann, J Sehouli. Gynecol Oncol 2016
21
23

Polypharmacy: misleading, but manageable.
Reamer L Bushardt, Emily B Massey, Temple W Simpson, Jane C Ariail, Kit N Simpson. Clin Interv Aging 2008
255
8

The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people.
T Kalsi, G Babic-Illman, P J Ross, N R Maisey, S Hughes, P Fields, F C Martin, Y Wang, D Harari. Br J Cancer 2015
146
8

Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality.
T L Jørgensen, J Hallas, S Friis, J Herrstedt. Br J Cancer 2012
161
8


Polypharmacy, aging, and cancer.
Jennifer Tam-McDevitt. Oncology (Williston Park) 2008
28
14

Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care.
Rupert A Payne, Gary A Abel, Anthony J Avery, Stewart W Mercer, Martin O Roland. Br J Clin Pharmacol 2014
110
6

Frailty in older adults: evidence for a phenotype.
L P Fried, C M Tangen, J Walston, A B Newman, C Hirsch, J Gottdiener, T Seeman, R Tracy, W J Kop, G Burke,[...]. J Gerontol A Biol Sci Med Sci 2001
6

Futile medication use in terminally ill cancer patients.
Rachel P Riechelmann, Monika K Krzyzanowska, Camilla Zimmermann. Support Care Cancer 2009
67
6

Use of prescription and nonprescription medications and supplements by cancer patients during chemotherapy: questionnaire validation.
Marie H Hanigan, Brian L Dela Cruz, David M Thompson, Kevin C Farmer, Patrick J Medina. J Oncol Pharm Pract 2008
24
16


Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer.
G Frasci, V Lorusso, N Panza, P Comella, G Nicolella, A Bianco, G De Cataldis, A Iannelli, D Bilancia, M Belli,[...]. J Clin Oncol 2000
341
6

Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study.
G Freyer, J-F Geay, S Touzet, J Provencal, B Weber, J-P Jacquin, G Ganem, N Tubiana-Mathieu, O Gisserot, E Pujade-Lauraine. Ann Oncol 2005
231
6

Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome.
Hagop Kantarjian, Susan O'brien, Jorge Cortes, Francis Giles, Stefan Faderl, Elias Jabbour, Guillermo Garcia-Manero, William Wierda, Sherry Pierce, Jianqin Shan,[...]. Cancer 2006
451
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.